<DOC>
	<DOCNO>NCT00816296</DOCNO>
	<brief_summary>The goal study investigate comparison intestinal microbiome patient obesity patient obesity Non-Alcoholic Fatty Liver Disease ( NAFLD ) . With protocol hope good understand microbiome individual work disease progression .</brief_summary>
	<brief_title>Evaluation Intestinal Microbiome Obese Kids</brief_title>
	<detailed_description>The goal study investigate compare composition intestinal microbiome patient obesity patient obesity Non-Alcoholic Fatty Liver Disease ( NAFLD ) . In addition , investigate relationship alteration intestinal microbiome , immune activation , progression NAFLD Non-Alcoholic Steatohepatitis ( NASH ) . We hypothesize alteration intestinal microbiome associate increase immune activation progression obesity associate NAFLD . Based hypothesis propose follow aim : Aim 1 . Identify enroll pediatric cohort obesity obesity/NAFLD study role intestinal microbiome development NAFLD . 1 . Enroll participants NEW Kids program treatment pediatric obesity Children 's Hospital Wisconsin ( CHW ) . Identify classify participant initial clinical evaluation , collect clinical metadata , obtain process blood stool sample analysis . Demonstrate feasibility show participant recruited participate specific study protocol . 2 . Follow study population nutritional/exercise intervention , follow collection clinical data , stool , blood sample . Aim 2 . Characterize intestinal microbiome quantitative PCR high throughput sequence analysis stool specimens participant obesity obesity/NAFLD . 1 . Demonstrate feasibility show sample aliquots patient fecal sample successfully analyze propose method yield consistent result duplicate sample . 2 . Compare sequence result metagenomic analysis study group particular attention bacterial composition metabolic capacity associate energy harvest , lipid carbohydrate transport , enhancement epithelial barrier integrity , choline metabolism . 3 . Investigate whether intervention ( nutritional/exercise ) result longitudinal alteration intestinal microbiome . Aim 3 . Characterize evidence systemic inflammation C-reactive protein ( CRP ) , Tumor necrosis factor alpha ( TNF-alpha ) Transforming growth factor beta 1 ( TGF-beta LPS Binding Protein ( LBP ) level , analyze result relationship intestinal microbiome presence NAFLD . 1 . Compare level systemic inflammatory marker participant obesity vs. obesity/NAFLD 2 . Investigate whether intervention ( nutritional/exercise ) result longitudinal alteration systemic inflammation .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Age 518 Years old Willing consent/undergo necessary procedure Obese ( BMI &gt; 30 ) Speak English Spanish cause liver disease chronic illnesses life threaten condition</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>NAFLD</keyword>
	<keyword>Obesity</keyword>
	<keyword>Microbiome</keyword>
</DOC>